AAV-RS1 (Applied Genetic Technologies Corporation)

N/A

Report date: 2023/10/26 16:19:54

Base Information

Drug NameAAV-RS1 (Applied Genetic Technologies Corporation)
Drug Alias NameAAV-RS1
ClassificationCell and gene therapy > Gene therapy > Viral vector-based gene therapy > Adeno-associated virus vector
Mechanisms of ActionRPGR gene transference
TargetsX-linked retinitis pigmentosa GTPase regulator
Therapy Area/IndicationsRetinoschisis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesApplied Genetic Technologies Corporation
China Registration ClassN/A

Develop Information

Active CompaniesApplied Genetic Technologies Corporation
Inactive CompaniesN/A
Active IndicationsRetinoschisis
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A